Neurogene (NGNE) Interest & Investment Income (2013 - 2026)

Neurogene (NGNE) posted Interest & Investment Income of $2.3 million for Q1 2026, down 15.41% on a QoQ basis from $2.7 million in Q4 2025, and down 29.48% year-over-year from $3.2 million in Q1 2025.

Neurogene (NGNE) Interest & Investment Income (2013 - 2026) Analysis & Trends

Neurogene's Interest & Investment Income history runs 12 years deep, the most recent figure standing at $2.3 million for Q1 2026.

  • Quarterly Interest & Investment Income fell 29.48% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (up 13.34% YoY) and the FY2025 annual result came in at $11.5 million, up 36.38% from the prior year.
  • Interest & Investment Income was $2.3 million for Q1 2026 at Neurogene, down from $2.7 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $3.2 million in Q1 2025 and bottomed at $650000.0 in Q3 2023.
  • A 4-year average of $1.9 million and a median of $2.3 million in 2026 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2024 — Interest & Investment Income jumped 198.58% — and 2026, when it declined 29.48%.
  • Neurogene's Interest & Investment Income stood at $781000.0 in 2023, then surged by 190.65% to $2.3 million in 2024, then grew by 17.75% to $2.7 million in 2025, then fell by 15.41% to $2.3 million in 2026.
  • Business Quant data shows NGNE's Interest & Investment Income at $2.3 million in Q1 2026, $2.7 million in Q4 2025, and $2.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Neurogene 771.78 Mn 771.78 Mn - 2.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.26 Mn
Dec 31, 2025 2.67 Mn
Sep 30, 2025 2.74 Mn
Jun 30, 2025 2.93 Mn
Mar 31, 2025 3.21 Mn
Dec 31, 2024 2.27 Mn
Sep 30, 2024 1.84 Mn
Jun 30, 2024 2.04 Mn
Mar 31, 2024 2.32 Mn
Dec 31, 2023 781,000.00
Sep 30, 2023 650,000.00
Jun 30, 2023 743,000.00
Mar 31, 2023 777,000.00
Mar 31, 2020 434,000.00
Mar 31, 2019 450,000.00
Sep 30, 2018 2,000.00
Jun 30, 2018 22,000.00
Mar 31, 2018 46,000.00
Dec 31, 2017 -621,000.00
Sep 30, 2017 236,000.00